Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial-Reference-Cited by-同舟云学术

Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial

Published:2016-04-19 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Krag Mette, ,Perner Anders,Wetterslev Jørn,Wise Matt P.,Borthwick Mark,Bendel Stepani,Pelosi Paolo,Keus Frederik,Guttormsen Anne Berit,Schefold Joerg C.,Møller Morten Hylander

Funder

Innovation Fund Denmark

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1331-3.pdf

Reference49 articles.

1. Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5:368–75.

2. Eddleston JM, Pearson RC, Holland J, Tooth JA, Vohra A, Doran BH. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med. 1994;22:1949–54.

3. Martin LF. Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy. Am Surg. 1994;60:169–74.